CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.
May 30th 2024
The CAR-T cell therapy, Breyanzi, has received FDA approval for relapsed or refractory mantle cell lymphoma.
My Oncologist Gave Me a Pseudo-Medication Taper That Made Me Feel Like I Was Losing Control
February 16th 2022In the midst of my treatment for mantle cell lymphoma, I had to suffer through the feeling of wanting to crawl out of my own skin when my oncologist gave me a medication tapering plan that was not gradual enough.
Clinical Trial Testing Effectiveness of LOXO-305 in Mantle Cell Lymphoma Now Open to Patients
February 9th 2022A phase 3 trial evaluating the safety and efficacy of the BTK inhibitor LOXO-305 in patients with previously treated mantle cell lymphoma is now open to patients across more than a dozen states.
Third Dose of COVID-19 Vaccine May Increase Protection in Immunocompromised Patients
August 19th 2021Patients who are immunocompromised, such as patients with blood cancers, may get the boosted immunity needed to reduce their risk for contracting COVID-19 and hospitalization for compilations related to the virus.